Issue : CP December 2017 online
Lack of evidence into paediatric cannabinoid use Subscription
The researchers found the strongest evidence of cannabinoid benefit in chemotherapy-induced nausea and vomiting, and in epilepsy
Magic mushrooms as a treatment for depression Subscription
Study sheds light on magic mushrooms’ mechanism in the brain in depression
Older adults at risk of medication-related dry mouth Subscription
In a meta-analysis of 26 studies, researchers found that medication use was significantly associated with dry mouth
Study highlights importance of people at high risk of diabetes being monitored during statin therapy
Claims of cancer drugs’ survival benefits must be accurate. To avoid fashion and fads, we must carefully examine the clinical and economic implications of newly approved cancer drugs before we seat them on the ‘breakthrough’ throne.
Digital ingestion tracking system in pills and medication adherence: future advantages and current limitations Subscription
The US Food and Drug Administration (FDA)’s approval of the first-ever digital pill, Abilify MyCite, an aripiprazole tablet for the treatment of schizophrenia, marks the closest we have come to revolutionising the way the uptake of pills is monitored.